健民集团涨2.06%，成交额4084.68万元，主力资金净流入316.39万元

Core Points - Jianmin Group's stock price increased by 2.06% on October 21, reaching 40.58 CNY per share, with a total market capitalization of 6.225 billion CNY [1] - The company has experienced a 0.49% decline in stock price year-to-date, with a 2.14% increase over the last five trading days [2] - Jianmin Group's main business involves the research, manufacturing, wholesale, and retail of pharmaceuticals, with 99.47% of revenue coming from product sales [2] Financial Performance - For the first half of 2025, Jianmin Group reported operating revenue of 1.805 billion CNY, a year-on-year decrease of 10.20%, and a net profit attributable to shareholders of 221 million CNY, down 7.83% year-on-year [2] - The company has distributed a total of 1.114 billion CNY in dividends since its A-share listing, with 476 million CNY distributed over the past three years [3] Shareholder Information - As of June 30, 2025, the number of shareholders increased by 29.30% to 17,000, while the average circulating shares per person decreased by 22.66% to 9,011 shares [2] - Major shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 203.04 million shares, and new entrant Rongtong Health Industry Flexible Allocation Mixed A/B [3]